O
Ozempic
OrganizationGLP-1 weight-loss medication Ozempic and its impact on public health and medicine
Mentions:24
7 Days:0
About
Ozempic is a GLP-1 weight-loss medication that has revolutionized the treatment of obesity and diabetes type 2. Recent news articles highlight the increasing demand for Ozempic, with US states dropping Medicaid coverage due to rising costs. The medication's benefits have been consolidated through clinical trials, showing significant weight loss (10-16%) in 1-2 years. However, concerns arise about its misuse for non-medical purposes, such as aesthetic enhancement, and potential abuse. Additionally, the patent expiration has led to a flood of cheap generics in Asia, raising concerns about safety and efficacy. As the medication's popularity grows, experts warn about the need for responsible use and caution against its misuse.
Last updated: April 30, 2026
Summary Evolution
Recent Coverage
Así se trata la ‘cara de Ozempic’: tratamientos más allá de la cirugía
Berberina: beneficios y mitos del mal llamado “Ozempic natural”
Asia’s flood of cheap Ozempic generics opens gates to weight-loss abuse
La genética explica por qué unos pierden más peso que otros con los fármacos para la obesidad, Ozempic y Mounjaro
Por qué los fármacos como Ozempic no funcionan igual para todos: influye la edad, el sexo y también los genes
Las advertencias de los expertos antes de comenzar a usar medicamentos contra la obesidad
El 'efecto Ozempic' ya se asoma en la cesta de la compra española: el gasto cae un 3,1% en los hogares que lo utilizan
El riesgo del ‘efecto Ozempic’ con la bulimia y la anorexia: favorece un modelo de belleza irreal
